Xcell Therapeutics Partners with Korean Society of Stem Cells for Education and More 

Xcell Therapeutics, a leading Korean media company, today announced that it has signed a business agreement with the Korean Society for Stem Cell Research (KSSCR) to advance the development of advanced regenerative medicine and advanced biopharmaceuticals in Korea.

Under the MOU, Xcell Therapeutics will support KSSCR educational symposia and regular conferences, online seminars, and corporate workshops related to advanced regenerative medicine and advanced biopharmaceuticals. The Korean Society of Stem Cells will run related educational and academic programs.

In the past, Xcell Therapeutics has sponsored product exhibits at the annual meeting of the Korean Society of Stem Cell Research (KSSCR). "Discussions on the development of advanced regenerative medicine and advanced biopharmaceuticals are in full swing," said Dr. Lee Yi-il, CEO of Xcell Therapeutics. "We hope that this support will serve as a foundation for the creation of practical results, including the development of a meaningful agenda for the society."

The Korean Stem Cell Society is a stem cell academic organization established in 2005 to support stem cell researchers in their academic activities. It has been prominent in academic activities such as holding academic events and publishing academic journals.

In 2019, it held an International Symposium in collaboration with the International Society for Stem Cell Research (ISSCR). Following the online conference earlier this year, the organization will hold a regular conference at BEXCO in Busan in August.

Xcell Therapeutics is the first Korean company to develop the world's first cGMP-grade Serum-Free Chemically Defined Media for hMSCs. It has been recognized overseas for its media technology and has built and operated a GMP-grade production plant in Yongin with an annual production capacity of 100,000 liters.  

Based on its excellent technology, Xcell Therapeutics passed the technical evaluation review for listing on the KOSDAQ in February, and was awarded the Minister of Trade, Industry and Energy Award last year for being selected as a bio-innovative company. This year, the company received the New Excellent Product certification, the most prestigious certificate issued by the South Korean government.

Source: https://www.news1.kr/articles/?4307330